These auto-Abs were against ACAN, a known biomarker in RA (50, 51) and ZMYM3 and RNF111, implicated in chronic lymphocytic leukemia (52, 53) and cancers (54), respectively. This evidence concerns the gene ACAN and rheumatoid arthritis.